Determination of an in vivo metabolite of a human immunodeficiency virus protease inhibitor in human plasma by high-performance liquid chromatography with tandem mass spectrometry
- 1 February 1997
- journal article
- Published by Elsevier in Journal of Chromatography A
- Vol. 762 (1-2) , 311-319
- https://doi.org/10.1016/s0021-9673(96)00702-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometryJournal of Chromatography A, 1996
- L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease InhibitorJournal of Medicinal Chemistry, 1994
- A rapid and specific assay, based on liquid chromatography—atmospheric pressure chemical ionization mass spectrometry, for the determination of MK-434 (a 5α-reductase inhibitor) and its metabolites in plasmaJournal of Pharmaceutical and Biomedical Analysis, 1994
- Capillary zone electrophoresis/tandem mass spectrometry for the determination of sulfonated azo dyesJournal of Mass Spectrometry, 1989
- High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samplesAnalytical Chemistry, 1986
- Effect of ketoconazole on hepatic oxidative drug metabolismClinical Pharmacology & Therapeutics, 1985
- Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDSScience, 1984
- Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDSScience, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984